|
ANP32E expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.198000E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.320200E-02 |
| Normal-vs-Stage2 |
1.760030E-01 |
| Normal-vs-Stage3 |
2.150200E-04 |
| Normal-vs-Stage4 |
4.38219999999712E-05 |
| Stage1-vs-Stage2 |
8.700800E-01 |
| Stage1-vs-Stage3 |
6.216100E-02 |
| Stage1-vs-Stage4 |
1.449960E-02 |
| Stage2-vs-Stage3 |
3.217200E-01 |
| Stage2-vs-Stage4 |
2.188400E-01 |
| Stage3-vs-Stage4 |
5.912800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.255200E-03 |
| Normal-vs-AfricanAmerican |
3.821100E-04 |
| Normal-vs-Asian |
1.836250E-01 |
| Caucasian-vs-AfricanAmerican |
1.323810E-01 |
| Caucasian-vs-Asian |
8.123600E-01 |
| AfricanAmerican-vs-Asian |
7.660000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.960600E-04 |
| Normal-vs-Female |
7.557800E-03 |
| Male-vs-Female |
7.128600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.813890E-02 |
| Normal-vs-Age(41-60Yrs) |
1.222100E-02 |
| Normal-vs-Age(61-80Yrs) |
8.030300E-04 |
| Normal-vs-Age(81-100Yrs) |
1.994420E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.736000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.957400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.731000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.187200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.192600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.042200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.784800E-01 |
| Normal-vs-Grade 2 |
1.022010E-01 |
| Normal-vs-Grade 3 |
8.11470000000591E-05 |
| Normal-vs-Grade 4 |
5.73849999963016E-07 |
| Grade 1-vs-Grade 2 |
4.641400E-01 |
| Grade 1-vs-Grade 3 |
7.235200E-03 |
| Grade 1-vs-Grade 4 |
2.355100E-04 |
| Grade 2-vs-Grade 3 |
2.244400E-03 |
| Grade 2-vs-Grade 4 |
1.77966999999057E-05 |
| Grade 3-vs-Grade 4 |
5.312300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.073800E-01 |
| Normal-vs-ccB subtype |
1.35900000031164E-07 |
| ccA subtype-vs-ccB subtype |
3.77229999459772E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.045100E-04 |
| Normal-vs-N1 |
1.957010E-01 |
| N0-vs-N1 |
6.739600E-01 |
|
|
